Komori
Kaken Pharmaceutical (4521) · InitiativeRestated

Compliance and internal control framework

First written in FY2017. 4 of 5 entries say "Restated". Latest entry: FY2022.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20222017: 120172018: 120182019: 120192020: 020202021: 120212022: 12022
Same theme, other companies
Establishment of a Corporate Ethics and Compliance FrameworkA theme 157 companies write about · 2 as a headwind · 156 as a tailwind

115 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 157 companies compared. The sentences above are computed from all 157.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「To ensure that the duties performed by the directors, executive officers and employees of our group comply with laws and the Articles of Incorporation, we have established the Kaken Pharmaceutical Corporate Code of Conduct and the Kaken Pharmaceutical Corporate Conduct Guidelines, which are common standards of conduct for the entire group, and promote awareness of and compliance with them.」

    The compliance framework based on group-wide codes and guidelines of conduct, an executive officer responsible for compliance and the Legal Department continues.
  2. FY2021RestatedAnnual report

    「To ensure that the duties performed by the directors, executive officers and employees of our group comply with laws and the Articles of Incorporation, we have established the Kaken Pharmaceutical Corporate Code of Conduct and the Kaken Pharmaceutical Corporate Conduct Guidelines, which are common standards of conduct for the entire group, and promote awareness of and compliance with them.」

    The compliance framework based on group-wide codes and guidelines of conduct, an executive officer responsible for compliance and the Legal Department continues.
  3. FY2019RestatedAnnual report

    「We have established the Kaken Pharmaceutical Corporate Code of Conduct and the Kaken Pharmaceutical Corporate Conduct Guidelines as standards of conduct common to the entire group, and promote awareness of and compliance with them.」

    The compliance framework based on group-wide codes and guidelines of conduct, an executive officer responsible for compliance and the Legal Department continues.
  4. FY2018RestatedAnnual report

    「To ensure that the duties performed by the directors, executive officers and employees of our group comply with laws and the Articles of Incorporation, we have established the Kaken Pharmaceutical Corporate Code of Conduct and the Kaken Pharmaceutical Corporate Conduct Guidelines, which are common standards of conduct for the entire group, and promote awareness of and compliance with them.」

    The disclosure of a compliance framework based on group-wide codes and guidelines of conduct, an executive officer responsible for compliance and the Legal Department continues.
  5. FY2017First statedAnnual report

    「To ensure that the duties performed by the directors, executive officers and employees of our group comply with laws and the Articles of Incorporation, we have established the Kaken Pharmaceutical Corporate Code of Conduct and the Kaken Pharmaceutical Corporate Conduct Guidelines, which are common standards of conduct for the entire group, and promote awareness of and compliance with them.」

    The disclosure describes a compliance framework based on group-wide codes and guidelines of conduct, an executive officer responsible for compliance, and oversight by the Legal Department.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kaken Pharmaceutical's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.